Please use this identifier to cite or link to this item:
http://acervodigital.unesp.br/handle/11449/133761
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bosquesi, Priscila Longhin | - |
dc.contributor.author | Melo, Tais Regina Ferreira | - |
dc.contributor.author | Vizioli, Ednir de Oliveira | - |
dc.contributor.author | Santos, Jean Leandro dos | - |
dc.contributor.author | Chung, Man Chin | - |
dc.date.accessioned | 2016-01-28T16:56:31Z | - |
dc.date.accessioned | 2016-10-25T21:28:49Z | - |
dc.date.available | 2016-01-28T16:56:31Z | - |
dc.date.available | 2016-10-25T21:28:49Z | - |
dc.date.issued | 2011 | - |
dc.identifier | http://dx.doi.org/10.3390/ph4111450 | - |
dc.identifier.citation | Pharmaceuticals, v. 4, p. 1450-1474, 2011. | - |
dc.identifier.issn | 1424-8247 | - |
dc.identifier.uri | http://hdl.handle.net/11449/133761 | - |
dc.identifier.uri | http://acervodigital.unesp.br/handle/11449/133761 | - |
dc.description.abstract | The design of new drugs with better physiochemical properties, adequateabsorption, distribution, metabolism, and excretion, effective pharmacologic potency andlacking toxicity remains is a challenge. Inflammation is the initial trigger of severaldifferent diseases, such as Alzheimer s disease, asthma, atherosclerosis, colitis, rheumatoidarthritis, depression, cancer; and disorders such as obesity and sexual dysfunction.Although inflammation is not the direct cause of these disorders, inflammatory processesoften increase related pain and suffering. New anti-inflammatory drugs developed usingmolecular hybridization techniques to obtain multiple-ligand drugs can act at one or multipletargets, allowing for synergic action and minimizing toxicity. This work is a review of newanti-inflammatory drugs developed using the molecular modification approach. | en |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | - |
dc.description.sponsorship | Conselho Nacional de Pesquisa (CNPq) | - |
dc.format.extent | 1450-1474 | - |
dc.language.iso | eng | - |
dc.source | Currículo Lattes | - |
dc.subject | Anti-inflammatory | en |
dc.subject | Hybridization | en |
dc.subject | Multiple-ligands | en |
dc.subject | Mutual prodrug | en |
dc.title | Anti-inflammatory drug design by molecular hybridization approach | en |
dc.type | outro | - |
dc.contributor.institution | Universidade Estadual Paulista (UNESP) | - |
dc.description.affiliation | Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Faculdade de Ciências Farmacêuticas de Araraquara (FCFAR), Departamento de Fármacos e Medicamentos, Rodovia Araraquara-Jaú, km 1, Campus Ville, CEP 14801902, Araraquara, SP, Brasil | - |
dc.description.affiliationUnesp | Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), Faculdade de Ciências Farmacêuticas de Araraquara (FCFAR), Departamento de Fármacos e Medicamentos, Rodovia Araraquara-Jaú, km 1, Campus Ville, CEP 14801902, Araraquara, SP, Brasil | - |
dc.description.sponsorshipId | FAPESP: 2010/12495-6 | - |
dc.description.sponsorshipId | FAPESP: 2010/50330-9 | - |
dc.description.sponsorshipId | CNPq: 308157/2010-9 | - |
dc.identifier.doi | 10.3390/ph4111450 | - |
dc.rights.accessRights | Acesso aberto | - |
dc.identifier.file | ISSN1424-8247-2011-04-1450-1474.pdf | - |
dc.relation.ispartof | Pharmaceuticals | - |
dc.identifier.lattes | 5737933639516944 | - |
dc.identifier.lattes | 3204277043366119 | - |
dc.identifier.lattes | 5435899068903487 | - |
dc.identifier.lattes | 4083068210623663 | - |
Appears in Collections: | Artigos, TCCs, Teses e Dissertações da Unesp |
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.